Target intelligence / Profile preview

Rho guanine nucleotide exchange factor 12 (ARHGEF12)

Target
ARHGEF12
Molecular classification
Guanine nucleotide exchange factor (GEF), RhoGEF protein, Signaling protein
01

Overview

Rho guanine nucleotide exchange factor 12 (ARHGEF12) is a cytoplasmic signaling protein encoded by the ARHGEF12 gene, functioning mainly as a guanine nucleotide exchange factor (GEF) for the RhoA small GTPase. It promotes the exchange of GDP for GTP on RhoA, switching it to an active state, which in turn activates downstream effectors controlling actin cytoskeleton organization and cellular processes like migration and proliferation. ARHGEF12 is a known effector of heterotrimeric G proteins (specifically GNA12 and GNA13) linked to G protein-coupled receptor signaling and may also act as a GTPase-activating protein (GAP) for GNA12 and GNA13. Clinically, ARHGEF12 can form gene fusions implicated in acute myeloid leukemia and is associated with other neoplastic and proliferative diseases.

Other names
Leukemia-associated RhoGEFLARGKIAA0382rho guanine nucleotide exchange factor 12RhoGEF12PRO2792ARHGC_HUMANKMT2A/ARHGEF12 fusion proteinGEF 12ARHGEF12
02

Mechanism of action

Drugs targeting this molecule would likely inhibit or modulate its GEF activity toward RhoA or its interaction with GPCR downstream signaling. Inhibition would impair activation of RhoA-mediated pathways important for cell movement and proliferation.

03

Biological functions

Signal transductionRegulation of RhoA GTPase activityRegulation of actin cytoskeletonCell migrationCell proliferationG protein-coupled receptor (GPCR) effectorGTPase-activating protein (GAP) for GNA12 and GNA13
04

Disease associations

Cancer (notably a fusion partner in acute myeloid leukemia)Combined oxidative phosphorylation deficiency 8NeoplasmLeukemia
05

Safety considerations

Targeting Rho GEF pathways may affect broad cellular processes including cytoskeletal dynamics and cell migration, raising possible off-target or systemic effectsPotential impact on hematopoietic system and immune responses due to roles in cell signaling

Beyond the preview

Go deeper on Rho guanine nucleotide exchange factor 12 (ARHGEF12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho guanine nucleotide exchange factor 12 (ARHGEF12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call